Literature DB >> 23292765

Estimation of finite population duration distributions from longitudinal survey panels with intermittent followup.

Dagmar M Hajducek1, J F Lawless.   

Abstract

We consider survival or duration times associated with spells (sojourns in some state) or events experienced by individuals in a population over a specified time period. Duration distributions can be estimated from data recorded during followup of panel members in longitudinal surveys, but adjustments for the sample design, population structure and losses to followup are typically required. We provided weighted Kaplan-Meier estimates that allow for these features and, in particular, adjust for dependent loss to followup through the use of inverse probability of censoring weights.

Mesh:

Year:  2013        PMID: 23292765     DOI: 10.1007/s10985-012-9241-5

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  5 in total

1.  Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests.

Authors:  J M Robins; D M Finkelstein
Journal:  Biometrics       Date:  2000-09       Impact factor: 2.571

2.  Collaborative targeted maximum likelihood for time to event data.

Authors:  Ori M Stitelman; Mark J van der Laan
Journal:  Int J Biostat       Date:  2010       Impact factor: 0.968

3.  Connections between survey calibration estimators and semiparametric models for incomplete data.

Authors:  Thomas Lumley; Pamela A Shaw; James Y Dai
Journal:  Int Stat Rev       Date:  2011-08       Impact factor: 2.217

4.  Product-limit survival functions with correlated survival times.

Authors:  R L Williams
Journal:  Lifetime Data Anal       Date:  1995       Impact factor: 1.588

5.  Marginal estimation for multi-stage models: waiting time distributions and competing risks analyses.

Authors:  Glen A Satten; Somnath Datta
Journal:  Stat Med       Date:  2002-01-15       Impact factor: 2.373

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.